(Q44604277)

4 December 2017

title

Melatonin: structural characterization of its non-enzymatic mono-oxygenate metabolite (English)

1 reference

4 December 2017

0 references

3

1 reference

4 December 2017

Giuseppe Avellone

2

0 references

author name string

Pasquale Agozzino

1

1 reference

4 December 2017

Leopoldo Ceraulo

4

1 reference

4 December 2017

Felice Filizzola

5

1 reference

4 December 2017

Maria C Natoli

6

1 reference

4 December 2017

Maria A Livrea

7

1 reference

4 December 2017

Luisa Tesoriere

8

1 reference

4 December 2017

publication date

1 November 2003

1 reference

Journal of Pineal Research

4 December 2017

published in

1 reference

4 December 2017

volume

35

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

269-275

1 reference

Melatonin as a therapeutic agent in the treatment of sleep disturbance in depression

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Use of melatonin in the treatment of paediatric sleep disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Improvement of sleep quality in elderly people by controlled-release melatonin.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Central melatonin receptors: implications for a mode of action

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Melatonin and its physiological and therapeutic properties

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Melatonin supplements for aging

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

A Biological Study on the Efficacy of Low–Dose Subcutaneous lnterleukin–2 plus Melatonin in the Treatment of Cancer–Related Thrombocytopenia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Melatonin in relation to cellular antioxidative defense mechanisms.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Melatonin protects human blood lymphocytes from radiation-induced chromosome damage

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Reaction of melatonin with lipoperoxyl radicals in phospholipid bilayers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Evaluation of the antioxidant activity of melatonin in vitro

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Acute Pharmacology of Melatonin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

The chemistry of melatonin's interaction with reactive species

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions*

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

A cyclic isomer of 2-hydroxymelatonin: a novel metabolite of melatonin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Identification of the factors affecting the rate of deactivation of hypochlorous acid by melatonin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Oxidation of melatonin by oxoferryl hemoglobin: a mechanistic study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Interactions of melatonin with membrane models: portioning of melatonin in AOT and lecithin reversed micelles

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Structural and physicochemical characterization of the inclusion complexes of cyclomaltooligosaccharides (cyclodextrins) with melatonin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Guest-to-host proton transfer in melatonin-beta-cyclodextrin inclusion complex by ionspray, fast atom bombardment and tandem mass spectrometry.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Redox cycling of human methaemoglobin by H2O2 yields persistent ferryl iron and protein based radicals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Melatonin effects on bone: experimental facts and clinical perspectives

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

Myocardial ischemia-reperfusion in rats: reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-079X.2003.00086.X

7 January 2021

10.1034/J.1600-079X.2003.00086.X

Identifiers

DOI

1 reference

4 December 2017

1 reference